Related Experiment Videos
Nephron mass as a risk factor for progression of renal disease
1Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abstract:
Partial ablation of renal mass initiates a cycle of progressive glomerular injury in the remnant. This process is associated with glomerular hypertrophy, hyperfiltration and systemic hypertension. Congenital deficits in nephron number are also associated with adverse effects on the kidney. Since intrauterine growth retardation is associated with formation of fewer nephrons, the recent observation that low birth weight is associated with increased risk of hypertension in later life raises the possibility that even modest reductions in nephron complement may also predispose to renal injury. Likewise, the numbers of viable nephrons supplied to renal, allograft recipients may be critical determinants of late allograft success or failure, since subsequent acute ischemia and rejection combine to lower the nephron complement to levels akin to the more extensive reductions in renal mass seen in patients with surgical reduction of a solitary kidney, in whom predisposition to hypertension and glomerulosclerosis is evident. This article summarizes recent findings suggesting that congenital nephron endowment is a significant factor in the pathogenesis of chronic renal disease and hypertension.
Insights
Lower nephron count, from birth or later injury, increases risk for chronic kidney disease and hypertension. This highlights the importance of nephron endowment for long-term kidney health.
Area of Science:
- Nephrology
- Renal Physiology
- Hypertension Research
Background:
- Reduced nephron number, whether congenital or acquired, is linked to kidney damage.
- Conditions like intrauterine growth retardation and low birth weight are associated with fewer nephrons and later hypertension.
- Renal allograft recipients with reduced nephron counts face risks similar to those with surgically reduced renal mass.
Purpose of the Study:
- To review evidence linking congenital nephron endowment to chronic kidney disease and hypertension.
- To explore the role of nephron number in the progression of renal injury.
- To investigate the implications of nephron deficits in various clinical scenarios.
Main Methods:
- Review of existing research on renal mass reduction and nephron number.
- Analysis of studies correlating birth weight, nephron count, and hypertension risk.
- Examination of outcomes in renal allograft recipients with varying nephron complements.
Main Results:
- Partial ablation of renal mass leads to progressive glomerular injury, hypertrophy, hyperfiltration, and hypertension.
- Lower congenital nephron endowment, indicated by low birth weight, correlates with increased hypertension risk.
- Nephron deficits in renal allografts, exacerbated by ischemia and rejection, mirror risks seen in surgically reduced kidneys.
Conclusions:
- Congenital nephron endowment is a crucial factor in the development of chronic renal disease.
- Adequate nephron number is vital for maintaining renal health and preventing hypertension.
- Understanding nephron endowment is key to managing kidney disease risk and allograft success.